DFNS
The short-seller slapdown
T3 Defense (NASDAQ: DFNS) got a very loud Monday morning headache: Fugazi Research published a bearish report accusing the company of leaning on capital markets wizardry more than actual operating performance. Shares still jumped more than 70%, because markets love a circus almost as much as they love a turnaround story.
The report’s core claim is pretty brutal: DFNS allegedly grew its narrative the old-fashioned Wall Street meme-stock way — by issuing stock and doing deals, not by generating durable profits. Fugazi pointed to first-quarter 2026 revenue of $3.6 million versus a net loss of $26.3 million, plus just $371,000 in gross profit against more than $4 million in operating expenses. That’s not exactly the kind of math that screams “printing money.”
Reverse splits, meet dilution anxiety
The report also took aim at DFNS’s capital structure. According to Fugazi, the company bumped its planned reverse split ratio from 1-for-50 to 1-for-125 after a Nasdaq minimum bid price deficiency notice. In plain English: when the stock gets too low, companies sometimes do a reverse split to make the share price look less like a penny-stock escape room.
Fugazi says the pattern looks familiar to the company’s prior life as Nukkleus, with reverse split activity, acquisitions, and then more share issuance. It also flagged the jump in goodwill from $7.6 million at year-end 2025 to $100 million by March 31, 2026, arguing that a lot of the balance sheet growth came from paper-funded acquisitions rather than real cash-generating assets.
Why investors should care
This is the kind of report that can matter even when the stock is already soaring:
- It puts pressure on the company’s credibility.
- It can scare off new buyers who hate dilution almost as much as they hate surprise fees.
- It raises the classic question: is this a real operating business, or a financing machine with a defense logo?
To be fair, the company also has some rosy operating updates from subsidiaries Rimon and Tiltan, including record July revenue and a growing backlog. So the bull case isn’t dead — but it now has to survive a very public credibility test.
Big picture: DFNS is acting like one of those stocks where the chart is screaming one thing and the balance sheet is whispering another. Investors now get to decide which voice they trust.